The intrapulmonary half-life and safety of aerosolized α1-protease inhibitor in normal volunteers

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 2, 1997, Pages 536-541

  Vogelmeier, Claus ^a   Kirlath, Iris ^b   Warrington, Steve ^b   Banik, Norbert ^b   Ulbrich, Ernst ^b   Du Bois, Roland M ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; LEUKOCYTE ELASTASE;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG HALF LIFE; DRUG SAFETY; DRUG TISSUE LEVEL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; PRIORITY JOURNAL;

EID: 0031045338     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.2.9032191     Document Type: Article

References (30)

1. Travis, J. 1988. Structure, function, and control of neutrophil proteinases. Am. J. Med. 84:37S-41S.
2. Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320:365-376.
3. Hubbard, R. C., M. L. Brantly, and R. G. Crystal. 1991. Proteases. In R. G. Crystal, J. B. West, P. J. Barnes, N. S. Cherniack, and E. R. Weibel, editors. The Lung - Scientific Foundations. Raven Press, New York. 1763-1773.
4. Sommerhoff, C. P., J. A. Nadel, C. B. Basbaum, and G. C. Caughney. 1990. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J. Clin. Invest. 85: 682-689.
5. Nakamura, H., K. Yoshimura, N. G. McElvaney, and R. G. Crystal. 1992. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J. Clin. Invest. 89:1478-1484.
6. Crystal, R. G. 1990. α1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J. Clin. Invest. 85:1343-1352.
7. Perlmutter, D. H., and J. A. Pierce. 1989. The al-antitrypsin gene and emphysema. Am. J. Physiol. 257:147-162.
8. Janoff, A. 1988. Emphysema: proteinase-antiproteinase imbalance. In J. I. Gallin, I. M. Goldstein, and R. Snyderman, editors. Inflammation: Basic Principles and Clinical Correlates. Raven Press, New York. 803-813.
9. Snider, G. L. 1992. Emphysema: the first two centuries - and beyond. Part I and II. Am. Rev. Respir. Dis. 146:1334-1344 and 1615-1622.
10. Goldstein, W., and G. Döring. 1986. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am. Rev. Respir. Dis. 134:49-56.
11. Suter, S., and I. Chevallier. 1991. Proteolytic inactivation of alpha1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis. Eur. Respir. J. 4:40-49.
12. Wewers, M. D., M. A. Casolaro, S. E. Sellers, S. C. Swayze, K. M. McPhaul, J. T. Wittes, and R. G. Crystal. 1987. Replacement therapy for α1-antitrypsin deficiency associated with emphysema. N. Engl. J. Med. 316:1055-1062.
13. Hubbard, R. C., S. Sellers, D. Czerski, L. Stephens, and R. G. Crystal. 1988. Biochemical efficacy and safety of monthly augmentation therapy for α1-antitrypsin deficiency. J.A.M.A. 260:1259-1264.
14. Schmidt, E. W., B. Rasche, W. T. Ulmer, N. Konietzko, M. Becker, J. P. Fallise, J. Lorenz, and R. Ferlinz. 1988. Replacement therapy for alpha-1-protease inhibitor deficiency in PiZ subjects with chronic obstructive lung disease. Am. J. Med. 84:63S-69S.
15. Hubbard, R. C., M. L. Brantly, S. E. Sellers, M. E. Mitchell, and R. G. Crystal. 1989. Delivery of proteins for therapeutic purposes by aerosolisation: direct augmentation of anti-neutrophil elastase defenses of the lower respiratory tract in α1-antitrypsin deficiency with an aerosol of α1-antitrypsin. Ann. Intern. Med. 111:206-212.
16. McElvaney, N. G., R. C. Hubbard, P. Birrer, M. S. Chernick, D. B. Caplan, M. M. Frank, and R. G. Crystal. 1991. Aerosol α1-antitrypsin treatment for cystic fibrosis. Lancet 337:392-394.
17. Behr, J., B. Degenkolb, K. Maier, B. Braun, T. Beinert, F. Krombach, C. Vogelmeier, and G. Fruhmann. 1995. Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis. Eur. Respir. J. 8:1286-1292.
18. Jochum, M., A. Pelletier, C. Boudier, G. Pauli, and J. G. Bieth. 1985. The concentration of leukocyte elastase-α1-proteinase inhibitor complex in bronchoalveolar lavage fluids from healthy human subjects. Am. Rev. Respir. Dis. 132:913-914.
19. Rennard, S. I., G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532-538.
20. Michalski, J. P., C. C. McCombs, S. Sheth, M. McCarthy, and R. de Shazo. 1985. A modified double antibody sandwich enzyme-linked immunosorbent assay for measurement of alpha-1-antitrypsin in biologic fluids. J. Immunol. Meth. 83:101-112.
21. Vogelmeier, C., R. C. Hubbard, G. A. Fells, H. P. Schnebli, R. C. Thompson, H. Fritz, and R. G. Crystal. 1991. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J. Clin. Invest. 87:482-488.
22. Pannell, R., D. Johnson, and J. Travis. 1974. Isolation and properties of human plasma aα1-proteinase inhibitor. Biochemistry 13:5439-5445.
23. Ogushi, F., G. A, Fells, R. C. Hubbard, S, D. Straus, and R. G. Crystal. 1987. Z-type α1-antitrypsin is less competent than Mi-type α1-antitrypsin as an inhibitor of neutrophil elastase. J. Clin. Invest. 80: 1366-1374.
24. Vogelmeier, C., R. Buhl, R. F. Hoyt, E. Wilson, G. A. Fells, R. C. Hubbard, H. P. Schnebli, R. C. Thompson, and R. G. Crystal. 1990. Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium. J. Appl. Physiol. 69:1843-1848.
25. Beatty, K., J. Bieth, and J. Travis. 1980. Kinetics of association of serine proteinases with native and oxidized α-1-proteinase inhibitor and α-1-antichymotrypsin. J. Biol. Chem. 255:3931-3934.
26. Johnson, D., and J. Travis. 1979. The oxidative inactivation of human α-1-proteinase inhibitor: further evidence for methionine at the active center. J. Biol. Chem. 254:4022-4026.
27. Smith, R. M., L. D. Traber, D. L. Traber, and R. G. Spragg. 1989. Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and sheep. J. Clin. Invest. 84:1145-1154.
28. Summers, Q. A. 1991. Inhaled drugs and the lung. Clin. Exp. Allergy 21:259-268.
29. Stolk, J., J. Camps, H. I. J. Feitsma, J. Hermans, J. H. Dijkman, and E. K. J. Pauwels. 1995. Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor. Thorax 50:645-650.
30. Banda, M. J., A. G. Rice, G. L. Griffin, and R. M. Senior. 1988. The inhibitory complex of human α1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant. J. Exp. Med. 167: 1608-1615.